Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4
Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4
Lake Street維持對Biolase的買入,將目標股價下調至0.4美元
Lake Street analyst Frank Takkinen maintains Biolase (NASDAQ:BIOL) with a Buy and lowers the price target from $1.5 to $0.4.
湖街分析師弗蘭克·塔基寧維持Biolase(納斯達克股票代碼:BIOL)的買入,並將目標股價從1.5美元下調至0.4美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。